Glucocorticoid Receptor 

 186 Products   186 Products   1696 Diseases   94663 News 


«12...2425262728293031323334...10631064»
  • ||||||||||  dexamethasone / Generic mfg., albendazole / Generic mfg., carbamazepine / Generic mfg.
    Journal:  Unmasking a Hidden Culprit: Neurocysticercosis, an Overlooked Cause of Acquired Epilepsy. (Pubmed Central) -  Jul 9, 2024   
    This case study underscores the importance of neuroimaging in investigating patients with neurological conditions like epilepsy, especially in developing countries. Early diagnosis and effective treatment are crucial in preventing and controlling NCC, reducing its impact on public health.
  • ||||||||||  dexamethasone / Generic mfg.
    Enrollment change, Trial withdrawal:  Dexamethasone/Pancreatic Clamp P&F (clinicaltrials.gov) -  Jul 9, 2024   
    P1,  N=0, Withdrawn, 
    Although PTP is rare, rapid diagnosis and management are required to control this potentially life-threatening condition. N=16 --> 0 | Not yet recruiting --> Withdrawn
  • ||||||||||  citarinostat (ACY-241) / BMS
    Phase classification, Trial completion date, Trial termination, Trial primary completion date, Combination therapy:  Study of ACY-241 Alone and in Combination With Pomalidomide and Dexamethasone in Multiple Myeloma (clinicaltrials.gov) -  Jul 9, 2024   
    P1,  N=85, Terminated, 
    N=16 --> 0 | Not yet recruiting --> Withdrawn Phase classification: P1a/1b --> P1 | Trial completion date: Jan 2024 --> Jun 2024 | Active, not recruiting --> Terminated | Trial primary completion date: Jan 2024 --> Jun 2024; Lack of efficacy
  • ||||||||||  Aliqopa (copanlisib) / Bayer
    Trial termination:  Copanlisib With Dose-Adjusted EPOCH-R in Relapsed and Refractory Burkitt Lymphoma and Other High-Grade B-cell Lymphomas (clinicaltrials.gov) -  Jul 8, 2024   
    P1,  N=8, Terminated, 
    Phase classification: P1a/1b --> P1 | Trial completion date: Jan 2024 --> Jun 2024 | Active, not recruiting --> Terminated | Trial primary completion date: Jan 2024 --> Jun 2024; Lack of efficacy Completed --> Terminated; The study was terminated early because copanlisib was removed from the market by the Food and Drug Administration (FDA) and the manufacturer.
  • ||||||||||  ABT-737 / AbbVie
    Journal:  Coumarin-based Aldo-Keto Reductase Family 1C (AKR1C) 2 and 3 Inhibitors. (Pubmed Central) -  Jul 8, 2024   
    Data from 30 healthy volunteers was leveraged: Endogenous ACTH and cortisol concentrations without any intervention as well as cortisol concentrations measured after dexamethasone suppression and single dose administration of (i) 0.5-10 Pan-AKR1C inhibition also did not potentiate the in vitro cytotoxicity of ABT-737, daunorubicin or dexamethasone, in two patient-derived T-cell ALL and pre-B-cell ALL cell lines.
  • ||||||||||  dexamethasone / Generic mfg.
    Journal:  Thermal Pharyngeal Injury Resulting From Vaping: A Case Report. (Pubmed Central) -  Jul 8, 2024   
    More likely, systemic concentration peaks following administration explain why oral physiological steroid doses are clinically effective. The patient was admitted to the hospital overnight for observation and treatment with analgesia and dexamethasone...The repeat nasopharyngolaryngoscopy showed improvement in the swelling of the epiglottis and arytenoids,
  • ||||||||||  mometasone furoate nasal spray / Generic mfg.
    Journal:  Effect of Olfactory Rehabilitation on the Recovery of Post-Coronavirus Disease Olfactory Dysfunction: A Randomized Controlled Trial. (Pubmed Central) -  Jul 8, 2024   
    Thirty-one patients were randomly assigned into three groups with 10 patients being given olfactory training (Group 1), another 10 being given mometasone furoate nasal spray/olfactory training (Group 2), and 11 patients being assigned to the control group (Group 3)...Statistically significant improvements were seen in the eODQ scores in all three groups. Conclusion No superiority of intervention for post-COVID-19 olfactory dysfunction was seen compared to control.
  • ||||||||||  methylprednisolone sodium succinate / Generic mfg.
    Journal:  Rhegmatogenous Retinal Detachment in Anterior Scleritis With Ulcerative Colitis. (Pubmed Central) -  Jul 8, 2024   
    Barricade laser was given, in addition to intravenous methylprednisolone (IVMP), followed by a tapering dose of oral prednisolone and topical dexamethasone 0.1% over three months...Treatment of non-progressive, subclinical RRD patients with UC and active AS can be delayed with regular follow-up. When RRD progressed and there was no AS activity, it was the window of opportunity for the success of scleral buckle and perioperative steroids.
  • ||||||||||  triamcinolone acetonide / Generic mfg.
    Journal:  A Prospective Study of Patients Presenting With Pre-sternal Keloids. (Pubmed Central) -  Jul 8, 2024   
    Treatment with intralesional injections of a combination of triamcinolone acetonide and hyaluronidase effectively relieves the symptoms and may be considered in patients not willing to undergo surgical intervention. Recurrences can occur and need further treatments.
  • ||||||||||  Ocaliva (obeticholic acid) / Intercept
    Review, Journal:  Progress in the Management of Patients with Cholestatic Liver Disease: Where Are We and Where Are We Going? (Pubmed Central) -  Jul 8, 2024   
    Considerable progress has been made in the management of cholestatic liver disease but there are still many opportunities and challenges. In this review, we summarized the recommended guidelines for the management of cholestatic disease and the progress of new drug research and development, in order to provide an important reference for the clinical practice of cholestatic liver disease.
  • ||||||||||  dexamethasone / Generic mfg., lenalidomide / Generic mfg.
    Review, Journal:  Extramedullary Intracranial Plasmacytomas: A Systematic Review of Literature. (Pubmed Central) -  Jul 8, 2024   
    RT alone demonstrated the highest effectiveness in managing EMIPs (30%), while QT as a sole intervention showed lower efficacy. However, a combination of dexamethasone, lenalidomide, and targeted RT displayed promising results, offering improved tumor response and increased safety.
  • ||||||||||  dexamethasone / Generic mfg., hydrocortisone / Generic mfg.
    Clinical protocol, Journal:  Exogenous glucocorticoids to improve extinction learning for post-traumatic stress disorder patients with hypothalamic-pituitary-adrenal-axis dysregulation: a study protocol description. (Pubmed Central) -  Jul 8, 2024   
    P4
    During next-day recall, strength of the extinction memory is determined by recovery of skin conductance and pupil dilation differential responding, whereas generalization is assessed by comparing responses between different spatial contexts. The integrated study described in the current protocol paper could inform a personalized treatment approach in which these PTSD patients may receive glucocorticoids as a treatment enhancer in trauma-focused therapies.Trial registration: The research project is registered in the European Union Drug Regulating Authorities Clinical Trials (EudraCT) database, https://eudract.ema.europa.eu/, EudraCT number 2020-000712-30.
  • ||||||||||  dexamethasone / Generic mfg.
    Retrospective data, Journal:  Effect of prenatal glucocorticoid therapy on hearing screening in premature infants (Pubmed Central) -  Jul 8, 2024   
    Among them, bronchopulmonary dysplasia was an independent risk factor forsecondary hearing screening referral?P<0.05?. A single course of adequate dexamethasone use within 48 h-7 d of prenatal has a positive effect on the preliminary hearing screening of preterm infants.
  • ||||||||||  dexamethasone / Generic mfg., dexmedetomidine / Generic mfg.
    Enrollment status, Combination therapy, Surgery:  Any: Dexmedetomidine in Postoperative Analgesia (clinicaltrials.gov) -  Jul 8, 2024   
    P2/3,  N=100, Enrolling by invitation, 
    A single course of adequate dexamethasone use within 48 h-7 d of prenatal has a positive effect on the preliminary hearing screening of preterm infants. Recruiting --> Enrolling by invitation
  • ||||||||||  dexamethasone / Generic mfg., rosiglitazone / Generic mfg.
    Preclinical, Journal:  Gene expression and characterization of clonally derived murine embryonic brown and brite adipocytes. (Pubmed Central) -  Jul 7, 2024   
    Additionally, the administration of rosiglitazone significantly enhances the brown and brite adipocyte phenotypes...In conclusion, EB5 and EB7 cell lines are valuable for research into adipocyte biology, providing insights into the differentiation and development of brown and beige adipocytes. Furthermore, they could be useful for the characterization of drugs targeting energy balance for the treatment of obesity and metabolic diseases.
  • ||||||||||  belrestotug (EOS-448) / iTeos, GSK, Keytruda (pembrolizumab) / Merck (MSD)
    Journal, Checkpoint inhibition:  Acute Eosinophilic Pneumonia Induced by Immune Checkpoint Inhibitor and Anti-TIGIT Therapy. (Pubmed Central) -  Jul 6, 2024   
    She was participating in a clinical trial using pembrolizumab and anti-TIGIT EOS-448, due to cancer progression...She was then empirically started on intravenous methylprednisolone for acute eosinophilic pneumonia without confirmatory bronchoscopy as she was at high risk with her previous pneumonectomy...Although bronchoscopy findings are part of AEP's diagnostic criteria, this case underscores the importance of clinical judgment in the prompt initiation of steroids, even without confirmatory bronchoscopy, in rapidly progressing cases. The role of anti-TIGIT therapy in this context remains uncertain.
  • ||||||||||  Kenalog-10 (triamcinolone acetonide) / BMS, Lamprene (clofazimine) / Novartis
    Cheilitis Granulomatosa: A Case Review (Exhibit Hall WD1-E1, Orange County Convention Center; In-Person) -  Jul 6, 2024 - Abstract #AAOMS2024AAOMS_483;    
    Medications including glucocorticoids (systemic, topical, intralesional), immunomodulators (clofazimine, hydroxychloroquine, fumaric acid esters), antibiotics (macrolides, tetracyclines, metronidazole), monoclonal antibodies, immunosuppressants (methotrexate, azathioprine), biologics (anti-tumor necrosis factor alpha [TNF-?]), and laser therapy have been documented in the treatment of GC6. The authors found success with a series of 4 intralesional corticosteroid injections (Kenalog 10mg/mL, 20 units per visit) resulted in remission after 3 months.
  • ||||||||||  dexamethasone / Generic mfg.
    Journal:  Rare Case of Adrenal Hemangioma Discovered Incidentally during Renal Colic Investigation. (Pubmed Central) -  Jul 5, 2024   
    Dexamethasone suppression test demonstrated suppressed cortisol response, indicating a non-functional mass...These lesions are associated with a good prognosis. One limitation of this report is the lack of preoperative adrenal magnetic resonance imaging of the incidental adrenal mass.
  • ||||||||||  methylprednisolone sodium succinate / Generic mfg.
    Journal:  Morvan Fibrillary Chorea Associated with Monoclonal B Cell Lymphocytosis. (Pubmed Central) -  Jul 4, 2024   
    He was treated with IV methylprednisolone and IVIG, with immediate improvement in neurologic symptoms...Classically, Morvan syndrome presents as a paraneoplastic disease secondary to thymomas. Our case demonstrates that there is an association between B cell lymphoproliferative disorders and Morvan syndrome.
  • ||||||||||  dexamethasone / Generic mfg.
    Journal:  Protective effect of Sasa veitchii extract against all-trans-retinoic acid-induced inhibition of proliferation of cultured human palate cells. (Pubmed Central) -  Jul 4, 2024   
    We demonstrated that all-trans-retinoic acid inhibited human embryonic palatal mesenchymal cell proliferation in a dose-dependent manner, whereas dexamethasone treatment had no effect on cell proliferation...Additionally, the expression levels of the genes that function downstream of the target genes ( ERBB2 and JADE1 ) of miR-4680-3p in signaling pathways were enhanced by cotreatment with Sasa veitchii extract and all-trans-retinoic acid compared to all-trans-retinoic acid treatment. These results suggest that Sasa veitchii extract suppresses all-trans-retinoic acid-induced inhibition of cell proliferation via modulation of miR-4680-3p expression.
  • ||||||||||  Rituxan (rituximab) / Roche
    Journal:  Severe lupus pneumonitis: A case of life-saving multimodal therapy with rituximab and corticosteroids. (Pubmed Central) -  Jul 4, 2024   
    This case highlights the importance of early and intensive immunosuppressive therapy in the management of severe lupus pneumonitis and underscores the utility of a multidisciplinary approach in overcoming diagnostic ambiguities. Furthermore, it contributes to the growing body of evidence supporting the efficacy of rituximab in severe lupus pneumonitis cases, offering insights into potential therapeutic avenues when conventional management strategies are inadequate or unsuitable.
  • ||||||||||  glibenclamide / Generic mfg., dexamethasone / Generic mfg., trimethoprim/sulfamethoxazole / Generic mfg.
    Journal:  Quality of Essential Medicines from Different Sources in Enugu and Anambra, Nigeria. (Pubmed Central) -  Jul 3, 2024   
    Nine out of 19 glibenclamide samples (47%) failed dissolution testing, and 7 out of 17 cotrimoxazole samples (41%) failed assay testing...Four samples (1.5%), all collected in markets, were clearly falsified and did not contain the declared active pharmaceutical ingredients. The proportion of falsified medicines was found to be lower than frequently reported in the media for Nigeria.
  • ||||||||||  vilanterol (GW642444H) / GSK, Incruse Ellipta (umeclidinium) / GSK, Veramyst (fluticasone furoate nasal spray) / GSK
    Journal:  Triple Therapy and Clinical Control in B+ COPD Patients: A Pragmatic, Prospective, Randomized Trial. (Pubmed Central) -  Jul 3, 2024   
    The proportion of falsified medicines was found to be lower than frequently reported in the media for Nigeria. The ANTES B+ study is the first to: (1) explore the efficacy and safety of triple therapy in a population of B+ COPD patients and (2) use a composite index (CC) as the primary result of a COPD trial.